REFERENCES
- Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am J Nephrol. 2008;28:1–7.
- Zhang W, Gong Z, Peng X, Tang S, Bi M, Huang W. Clinical characteristics and outcomes of rural patients with ESRD in Guangxi, China: One dialysis center experience. Int Urol Nephrol. 2010;42:195–204.
- Dialysis and Transplantation Registration Group. The report about the registration of dialysis and transplantation in China. Chin J Nephrol. 1999;17:77–78.
- Cai GY, Chen XM. Immunoglobulin A nephropathy in China: Progress and challenges. Am J Nephrol. 2009;30:268–273.
- Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: Practice in China. Kidney Int. 2005;94:S63–S67.
- Lin SY. Nephrology in China: A great mission and momentous challenge. Kidney Int. 2003;63(Suppl. 83):S108–S110.
- Han Q, Chen L, Evans TG, Summerskill W. Recent scientific health developments in China. Lancet 2010;375:1055–1056.
- Zhou P, Leydesdorff L. ISSI Newsletter No. 13. March 2008:7–9.
- Lawrence PA. The politics of publication. Nature 2003;422:259–261.
- Wallin JA. Bibliometric methods: Pitfalls and possibilities. Basic Clin Pharmacol Toxicol. 2005;97:261–275.
- ISI Journal Citation Reports, Institute for Scientific Information. 2006. Available at: http://isiknowledge.com. Accessed April 20, 2008.
- http://www.nytimes.com/2010/08/16/business/global/16yuan.html. Accessed February 22, 2011.
- Wells WA. The returning tide: How China, the world’s most populous country, is building a competitive research base. J Cell Biol. 2007;176:376–401.
- Goh KL, Farrell GC. Publications from China: The sleeping giant awakens. J Gastroenterol Hepatol. 2008;23:341–343.
- Thomson Scientific. Scientific output in China is growing. 2007. Available at: http://scientific.thomson.com/press/2007/8423909. Accessed February 22, 2011.
- http://www.telegraph.co.uk/news/worldnews/asia/china/7075698/China-to-lead-world-scientific-research-by-2020.html. Accessed February 21, 2011.
- Liu J. Scientific publication in China: An overview and some thoughts on improvement. Sci Ed. 2004;27:120–121.
- Despite Decline in Share of Global Output, US Science Impact Still Strong, Says Thomson Reuters. Available at: http://science.thomsonreuters.com/press/2009/8500846/. Accessed February 21, 2011.
- Andersen J, Belmont J, Cho CT. Journal impact factor in the era of expanding literature. J Microbiol Immunol Infect. 2006;39:436–443.
- Falagas ME, Kouranos VD, Arencibia-Jorge R, Karageorgopoulos DE. Comparison of SCImago journal rank indicator with journal impact factor. FASEB J. 2008;22:2623–2628.
- Strippoli GFM, Craig JC, Schena FP. The number, quality and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol. 2004;15:411–419.
- Zeeuw DD, De Graeff PA. Clinical trial in nephrology at hard end point? J Am Soc Nephrol. 2004;15:506–508.
- Cheng TO. Cardiology in contemporary China: An update. Int J Cardiol. 2008;126:147–159.
- Mervis J. China’s unique environment favors large intervention trials. Science 1995;270:1149–1151.
- Wang J. Evidence-based medicine in China. Lancet 2010;375:532–533.
- The Chinese Clinical Trial Register. Available at: http://www.chictr.org. Accessed December 14, 2009.
- Liu X, Li Y, Yin S, Song S. Result publication of Chinese trials in World Health Organization primary registries. PLoS One. 2010;5:e12676.
- Chen N, Wang W, Huang Y, . Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009;24:2117–2123.
- Chen W, Chen W, Wang H, . Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant. 2009;24:1205–1212.
- Shan Y, Zhang Q, Liu Z, Hu X, Liu D. Prevalence and risk factors associated with chronic kidney disease in adults over 40 years: A population study from Central China. Nephrology (Carlton). 2010;15:354–361.